These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 14858262)

  • 1. [Conteben resistant tuberculosis bacteria].
    POTHMANN FJ; REINECKE G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(5):487-97. PubMed ID: 14858262
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of serum from patients treated with conteben upon growth of the tubercle bacillus. III. The behavior of bacteria resistant to conteben; an indirect method of determining conteben blood levels].
    GEKS FJ
    Z Hyg Infektionskr; 1951; 132(2):162-72. PubMed ID: 14836997
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of the effect of conteben on the tubercle bacillus; the effect of conteben therapy upon the morphology and virulence of tubercle bacilli present in the sputum].
    BIENENGRABER A; URBACH H
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(1):68-82. PubMed ID: 14820743
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of conteben and vitamin D2 therapy on Mycobacterium tuberculosis; comparative investigations on the conteben sensitivity in vitro and the course of skin tuberculosis under conteben therapy].
    VELTMAN G
    Zentralbl Bakteriol Orig; 1952 Aug; 158(6):417-25. PubMed ID: 13006962
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect in vitro of conteben, streptomycin, and PAS on TB-VI-resistant tubercle bacilli].
    von VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1951; 105(4):354-61. PubMed ID: 14847988
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tubercle bacillus resistance and the drug blood level during conteben, PAS and streptomycin therapy of pulmonary tuberculosis].
    HOFMANN P; NICKEL L
    Tuberkulosearzt; 1950 Dec; 4(12):695-702. PubMed ID: 14809773
    [No Abstract]   [Full Text] [Related]  

  • 7. [The relation of in vitro conteben sensitivity to conteben therapy; a study on conteben resistant tuberculosis strains].
    VELTMAN G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 106(5):413-20. PubMed ID: 14925075
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance determination of tubercle bacteria against streptomycin, PAS, conteben, isoniazid and paratebin].
    VON VIETINGHOFF-SCHEEL O
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1953; 108(6):490-501. PubMed ID: 13081562
    [No Abstract]   [Full Text] [Related]  

  • 9. [On method in the determination of the tubercle bacillus' resistance to conteben].
    WAGNER WH; SCHMIDT J
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1952; 107(6):453-9. PubMed ID: 13032011
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined therapy of urogenital tuberculosis with specific substances of tubercle bacillus (tebeprotin, phthioic acid phosphatide and conteben)].
    TOENNIESSEN E; KORNBECK E
    Med Klin; 1951 Jun; 46(24):687-8. PubMed ID: 14862813
    [No Abstract]   [Full Text] [Related]  

  • 11. [Practical viewpoints of resistance against streptomycin, PAS, conteben].
    UNHOLTZ K
    Tuberkulosearzt; 1952 Aug; 6(8):451-9. PubMed ID: 13005732
    [No Abstract]   [Full Text] [Related]  

  • 12. [Present status of tuberculosis therapy with conteben, a substance of the thiosemicarbazones group].
    Rev Bras Tuberc Doencas Torac; 1950; 18(128):173-89. PubMed ID: 14781490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Animal experiments on the physiology of tubercle bacilli in foci of skin tuberculosis treated with conteben and vitamin D2].
    VELTMAN G
    Arch Dermatol Syph; 1951 Nov; 193(4):305-24. PubMed ID: 14944185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiments on combined therapeutic use of streptomycin, conteben and PAS; erythrocyte modifications due to conteben].
    MOESCHLIN S; DEMIRAL B
    Helv Med Acta; 1950 Oct; 17(4-5):568-71. PubMed ID: 14793861
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the metabolism of the tubercle bacillus following conteben administration with the aid of Warburg's method; contribution to the problem of virulence change following thiosemicarbazone administration].
    VELTMAN G; MIETHKE K
    Arztl Wochensch; 1953 Mar; 8(12):276-80. PubMed ID: 13057788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the otorhinolaryngological localizations of tuberculosis with thiosemicarbazones (conteben)].
    STACHOWSKY L
    Rev Sanid Asist Soc; 1955; 20(5-6):319-38. PubMed ID: 13350962
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of conteben on pulmonary tuberculosis].
    UNVERRICHT W
    Arztl Wochensch; 1950 May; 5(18):284-7. PubMed ID: 15425394
    [No Abstract]   [Full Text] [Related]  

  • 18. [Conteben therapy in childhood tuberculosis].
    RUSS E
    Kinderarztl Prax; 1950; 18(11-12):521-5. PubMed ID: 14814791
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pulmonary tuberculosis with Tb I/698 (conteben)].
    SCHMIEDT E; PFROGNER E
    Dtsch Gesundheitsw; 1950 Jun; 5(22):695-7. PubMed ID: 15427463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Unspecified effect mechanism of conteben in tuberculosis].
    BIRK G; ROSGEN M
    Dtsch Med Wochenschr; 1951 Jun; 76(26):865-7. PubMed ID: 14849440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.